(Q40754720)

23 September 2017

title

Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: Initial response and long-term results in 54 patients (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

28 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

28 November 2022

author name string

N. Niederle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

T. Moritz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

O. Kloke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

U. Wandl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

D. May

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

R. Becher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

T. Franz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

B. Opalka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

C. G. Schmidt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799485

28 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1799485

28 November 2022

publication date

1 January 1991

1 reference

full work available at URL

23 September 2017

https://api.elsevier.com/content/article/PII:027753799190556S?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

https://api.elsevier.com/content/article/PII:027753799190556S?httpAccept=text/plain

28 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

European Journal of Cancer

28 November 2022

published in

1 reference

23 September 2017

volume

27 Suppl 4

1 reference

23 September 2017

page(s)

S7-14

1 reference

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

23 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Chronic granulocytic leukemia

28 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Chronic myelogenous leukemia--new concepts (first of two parts).

28 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

28 November 2022

Chronic myeloid leukemia

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

28 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

The Philadelphia chromosome and Philadelphia chromosome mosaicism in chronic granulocytic leukemia

28 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

28 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

28 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

28 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

28 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome

28 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity

28 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products

28 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

28 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Chronic myelogenous leukemia--new concepts (second of two parts).

28 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins

28 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

28 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Bone marrow transplantation for chronic granulocytic leukaemia

28 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Marrow transplantation for the treatment of chronic myelogenous leukemia

28 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia

28 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Inhibitory Effects of Human Leukocyte and Fibroblast Interferons on Normal and Chronic Myelogenous Leukemic Granulocytic Progenitor Cells

28 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Cytotoxic effects of interferon in vitro on granulocytic progenitor cells

28 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Effect of recombinant gamma interferon on chronic myelogenous leukemia bone marrow progenitors

28 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Effect of interferon on pluripotent hemopoietic progenitors (CFU-GEMM) derived from human bone marrow

28 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

28 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Molecular analysis of both translocation products of a Philadelphia-positive CML patient

28 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies

28 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

28 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Sensitivity of Ph 1 + CFU-GM to human recombinant interferon alpha and gamma alone and in combination

28 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

[alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia]

28 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferon

28 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha

28 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia

28 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease

28 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90556-S

28 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1799485

28 November 2022

1 reference